Aspect Biosystems Expands Novo Nordisk Partnership, Signaling Broader Pharma Interest3DPrint.com | Additive Manufacturing Business
Aspect Biosystems and Novo Nordisk are expanding their partnership. The duo had previously made a deal worth up to $2.6 billion in 2023. Then the deal centered on drug discovery and the use of Aspect’s bioprinting platform to develop therapies. Under the new deal, Aspect will develop therapies based on stem cell-derived islets. The joint […]





